Trump's New Drug Platform Could Shake Up Pharma Industry
TL;DR
Mark Cuban comments on President Trump's new drug platform, TrumpRx.gov, which aims to sell discounted prescription drugs directly to consumers. Cuban sees potential if it can challenge existing pharmacy benefit managers (PBMs), though current market reactions suggest skepticism. The platform partners with Pfizer and could influence drug pricing, but experts doubt it will significantly lower costs for most Americans due to systemic issues with PBMs and insurance-based purchasing.
Topics:nationbusiness#business#drug-pricing#healthcare-disruption#mark-cuban#pharmaceuticals#trumprxgov
- Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’ Fortune
- Trump claimed a win on drug prices, but Big Pharma also scored The Washington Post
- Why Pfizer’s Trump Deal Is Good News for All of Big Pharma The Wall Street Journal
- Trump announces 'TrumpRx' website for pharmaceutical drugs after Pfizer deal ABC News - Breaking News, Latest News and Videos
- Donald Trump’s cure for drug prices is worse than the disease The Economist
Want the full story? Read the original reporting
Read on Fortune